Ayinde O and Ross JDC. Factors associated with severity and resolution of intramuscular injection site pain following treatment for uncomplicated gonorrhoea: A prospective cohort study of GToG trial participants. Sexual Health 2020
Mensforth S and Ross JDC. Spontaneous clearance of genital and extra-genital Neisseria gonorrhoeae: data from the GToG trial. Sex Trans Infect 2020;96:556–561
Savaris RF, Fuhrich DG, Maissiat J, Duarte RV and Ross JDC. Antibiotic therapy for pelvic inflammatory disease. Cochrane Database of Systematic Reviews 2020, Issue 8. Art. No.: CD010285.
Spence T, Kander I, Walsh J, Griffiths J and Ross JDC. Perceptions and Experiences of Internet-Based Testing for Sexually Transmitted Infections: Systematic Review and Synthesis of Qualitative Research. Journal of Medical Internet Research 2020;22(8):e17667
Unemo M, Ross JDC, Serwin A, Gomberg M, Cusini M and Jensen J. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. International Journal of STD & AIDS. 2020
Ross JDC, Brittain C, Cole M, Dewsnap C, Harding J, Hepburn T, Jackson L, Keogh M, Lawrence T, Montgomery AA, Roberts TE, Sprange K, Tan W, Thandi S, White J, Wilson J and Duley L, on behalf of the G-ToG Trial Team. Gentamicin compared with Ceftriaxone for the treatment of gonorrhoea: a randomised trial (G-ToG Trial). Lancet 2019;393:2511-2520
Caswell R, Ross JDC and Lorimer K. Measuring experience and outcomes in patients reporting sexual violence who attend a health care setting: a systematic review. Sex Trans Infect 2019;95:419-427
Mensforth S and Ross JDC. Should we still use azithromycin for gonorrhoea treatment? Sexual Health 2019;16:442–448.
Cole M, Tan W, Fifer H, Brittain Ce, Duley L, Hepburn T, Lawrence T, Montgomery A, Sprange K, Thandi S, Churchward C, Tripodo F, Woodford N and Ross JDC. Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea; the relationship between antibiotic minimum inhibitory concentration and clinical outcome. Journal of Antimicrobial Chemotherapy 2019.
Watkins J, Ross JDC, Thandi S, Brittain C, Kai J and Griffiths F. Acceptability of and Treatment Preferences for Recurrent Bacterial Vaginosis - Topical Lactic Acid Gel or Oral Metronidazole Antibiotic: Qualitative Findings from the VITA Trial. PLoS ONE 2019; 14(11): e0224964.